Related Experiment Videos
Tissue iron loading and histopathological changes in hypotransferrinaemic mice
R J Simpson1, A M Konijn, M Lombard
1Department of Clinical Biochemistry, King's College School of Medicine and Dentistry, London, U.K.
The Journal of Pathology
|November 1, 1993
Summary
Hypotransferrinaemic (hpx/hpx) mice models show significant iron loading in the liver and pancreas, leading to tissue damage. This study details iron accumulation patterns and associated organ pathology in this genetic hemochromatosis model.
Area of Science:
- Biomedical Science
- Animal Models
- Iron Metabolism
Background:
- Genetic hemochromatosis involves excessive iron absorption and storage.
- Hypotransferrinaemic (hpx/hpx) mice serve as a model to study iron overload disorders.
- Understanding tissue-specific iron loading is crucial for disease progression insights.
Purpose of the Study:
- To investigate tissue iron loading patterns in hpx/hpx mice.
- To evaluate the resulting organ damage as a model for genetic hemochromatosis.
- To characterize the distinct features of iron accumulation and pathology.
Main Methods:
- Utilized hpx/hpx mice as a model for genetic hemochromatosis.
- Assessed iron deposition via staining in various tissues (liver, pancreas, heart, intestine).
- Examined histological changes including fibrosis, inflammation, and cellular infiltration.
Main Results:
- Liver iron loading preceded pancreatic and cardiac iron accumulation.
- Significant iron staining and macrophage infiltration observed in exocrine pancreas, liver, and smooth muscle.
- Pancreatic fibrosis and secretory epithelium loss, alongside liver inflammatory changes, were noted.
- Elevated serum aspartate aminotransferase and plasma glucose in hpx/hpx mice.
Conclusions:
- One-year-old hpx/hpx mice exhibit liver and pancreatic damage secondary to tissue iron overload.
- The observed iron loading pattern and tissue damage present features distinct from typical hemochromatosis.
- The hpx/hpx mouse model offers valuable insights into iron metabolism disorders, with unique pathological characteristics.